Similar Articles
631 Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
632 Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma
633 Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
634 Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
635 Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection
636 Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma
637 Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma
638 Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
639 Utility of positron emission tomography-computed tomography scan in detecting residual hepatocellular carcinoma post treatment: Series of case reports
640 Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA